Retraction

Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1007/s10549-015-3399-y

Citations (18)

18
Total Citations
11
Post-Retraction
(61.1%)
4
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
5 Within 1 year
6 After 2+ years
3409 Days since retraction (latest)
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Aug 2024
3409 days after retraction
Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
Xuewei Zheng, Haodi Ma, Jingjing Wang et al. (7 authors)
Translational Oncology Open Access
Published: Sep 2022
29 citations
2692 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Jan 2021
2098 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Jun 2020
1865 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Dec 2017
950 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Aug 2017
830 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Jan 2016
263 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Sep 2015
123 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Jul 2015
61 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Jun 2015
60 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: May 2015
24 days after retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Jan 2015
97 days before retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Nov 2014
181 days before retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Oct 2014
212 days before retraction
Paper citing Suppression of the xCT-CD44v antiporter system sen...
Unknown Authors
Unknown Journal
Published: Oct 2014
212 days before retraction
Quick Stats
Total Citations: 18
Years Since Retraction: 10.5 years
Open Access: No
Last Checked: Never
Related Papers
A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epit…
Breast Cancer Research and Treatment • 49 citations
Glypican-3 regulates migration, adhesion and actin cytoskel…
Breast Cancer Research and Treatment • 80 citations
Glypican-3 reexpression regulates apoptosis in murine adeno…
Breast Cancer Research and Treatment • 33 citations
Inhibition of breast cancer metastasis with microRNA-302a b…
Breast Cancer Research and Treatment • 50 citations
FoxM1 down-regulation leads to inhibition of proliferation,…
Breast Cancer Research and Treatment • 123 citations